Hypovitaminosis D in acutely injured pediatric burn patients

Journal of the American Dietetic Association

Volumn 104, Issue 6, 2004, Pages 931-941

  Gottschlich, Michele M ^a,b   Mayes, Theresa ^a   Khoury, Jane ^d   Warden, Glenn D ^a,c  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ANABOLIC AGENT; CALCITRIOL; HYDROCORTISONE; LIOTHYRONINE; OXANDROLONE; PARATHYROID HORMONE; SERUM ALBUMIN; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BODY SURFACE; BURN; CHILD; ENDOCRINE FUNCTION; HORMONE BLOOD LEVEL; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADOLESCENT; ANABOLIC AGENTS; BURNS; CHILD; CHILD, PRESCHOOL; ERGOCALCIFEROLS; GROWTH HORMONE; HUMANS; HYDROCORTISONE; INCIDENCE; INFANT; OXANDROLONE; PARATHYROID HORMONE; PREVALENCE; SERUM ALBUMIN; THYROTROPIN; THYROXINE; TRAUMA SEVERITY INDICES; TRIIODOTHYRONINE; VITAMIN D; VITAMIN D DEFICIENCY;

ENTEROBACTERIA PHAGE T4;

EID: 2542574784     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jada.2004.03.020     Document Type: Article

References (158)

1. Herndon D.N., Ramzy P.I., DebRoy M.A., Zheng M., Ferrando A.A., Chinkes D.L., Barret J.P., Wolfe R.R., Wolf S.E. Muscle protein catabolism after severe burn Effects of IGF-1/IGFBP-3 treatment. Ann Surg. 229:1999;713-722
2. Hart D.W., Wolf S.E., Chinkes D.L., Gore D.C., Mlcak R.P., Beauford R.B., Obeng M.K., Lal S., Gold W.F., Wolfe R.R., Herndon D.N. Determinants of skeletal muscle catabolism after severe burn. Ann Surg. 232:2000;455-465
3. Rutan R.L., Herndon D.N. Growth delay in postburn pediatric patients. Arch Surg. 125:1990;392-395
4. Aili Low J.F., Barrow R.E., Mittendorfer B., Jeschke M.G., Chinkes D.L., Herndon D.N. The effect of short-term growth hormone treatment on growth and energy expenditure in burned children. Burns. 27:2001;447-452
5. Low J.F., Herndon D.N., Barrow R.E. Effect of growth hormone on growth delay in burned children A 3-year follow-up study. Lancet. 354:1999;1789
6. Klein G.L., Herndon D.N., Langman C.B., et al. Long-term reduction in bone mass after severe burn injury in children. J Pediatrics. 126:1995;252-256
7. Klein G.L., Herndon D.N., Rutan T.C., et al. Bone disease in burn patients. J Bone Miner Res. 8:1993;337-345
8. Klein G.L., Herndon D.N., Goodman W.G., et al. Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone. 17:1995;455-460
9. Schaffler M.B., Li X.J., Jee W.S., Ho S.W., Stern P.J. Skeletal tissue responses to thermal injury An experimental study. Bone. 9:1988;397-406
10. Edelman L.S., McNaught T., Chan G., Morris S.E. Bone mineral density changes following burn injury. J Burn Care Rehabil. 23:(suppl):2002;S84
11. Klein G.L., Wolf S.E., Goodman W.G., Phillips W.A., Herndon D.N. The management of acute bone loss in severe catabolism due to burn injury. Horm Res. 48:(Suppl 5):1997;83-87
12. Edelman L.S., McNaught T., Chan G.M., Morris S.E. Sustained bone mineral changes following burn injury. J Surg Research. 114:2003;172-178
13. Mayes T., Gottschlich M., Scanlon J., Warden G.D. Four-year review of burns as an etiologic factor in the development of long bone fractures in pediatric patients. J Burn Care Rehabil. 24:2003;279-284
14. Evans E.B. Orthopaedic measures in the treatment of burns. J Bone Joint Surg. 48-A:1966;643-669
15. Klein G.L., Langman C.B., Herndon D.N. Vitamin D depletion following burns in children A possible factor in post-burn osteopenia. J Trauma. 52:2002;346-350
16. Francis R.M., Peacock M. Local action of oral 1, 25- dihydroxycholecalciferol on calcium absorption in osteoporosis. Am J Clin Nutr. 46:1987;315-318
17. Bucuvalas J.C., Heubi J.E., Specker B.L., Gregg D.J., Yergey A.L., Vieira N.E. Calcium absorption in bone disease associated with chronic cholestasis during childhood. Hepatology. 12:1990;1200-1205
18. Wray C.J., Mayes T., Khoury J., Warden G.D., Gottschlich M. The 2002 Moyer Award. Metabolic effects of vitamin D on serum calcium, magnesium, and phosphorus in pediatric burn patients. J Burn Care Rehabil. 23:2002;416-423
19. Dawson-Hughes B., Harris S.S., Krall E.A., Dallal G.E. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 337:1997;670-676
20. Heubi J.E., Hollis B.W., Specker B., Tsang R.C. Bone disease in chronic childhood cholestasis, I. Vitamin D absorption and metabolism. Hepatology. 9:1989;258-264
21. Heubi J.E., Hollis B.W., Tsang R.C. Bone disease in chronic childhood cholestasis, II. Better absorption of 25-OH vitamin D than vitamin D in extrahepatic biliary atresia. Pediatr Res. 27:1990;26-31
22. Davies M., Heys S.E., Selby P.L., Berry J.L., Mawer E.B. Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1, 25-dihydroxyvitamin D levels. Implications for metabolic bone disease. J Clin Endocrinol Metab. 82:1997;209-212
23. Gartner L.M., Greer F.R. Section on Breastfeeding and Committee on Nutrition. Prevention of rickets and vitamin D deficiency New guidelines for vitamin D intake. Pediatrics. 111:2003;908-910
24. Bordier P., Rasmussen H., Marie P., Miravet L., Gueris J., Ryckwaert A. Vitamin D metabolites and bone mineralization in man. J Clin Endocrinol Metab. 46:1978;284-294
25. DeLuca H.F. New developments in the vitamin D endocrine system. J Am Diet Assoc. 80:1982;231-236
26. Clemens T.L., Vitamin.D. Recent advances in basic research and clinical assay methodology. J Clin Immunoassay. 9:1986;183-192
27. Janssen H.C.J.P., Samson M.M., Verhaar H.J. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr. 75:2002;611-615
28. Rimaniol J.M., Authier F.J., Chariot P. Muscle weakness in intensive care patients Initial manifestation of vitamin D deficiency. Intensive Care Med. 20:1994;591-592
29. Vu D., Ong J.M., Clemens T.L., Kern P.A. 1, 25-dihydroxyvitamin D induces lipoprotein lipase expression in 3T3-L1 cells in association with adipocyte differentiation. Endocrinology. 1137:1996;1540-1544
30. Hypponen E., Laara E., Reunanen A., Jarvelin M.R., Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes A birth-cohort study. Lancet. 358:2001;1500-1503
31. Tsoukas C.D., Provvedini D.M., Manolagas S.C. 1, 25 dihydroxyvitamin D3 A novel immunoregulatory hormone. Science. 224:1984;1438-1439
32. Manolagas S.C., Provvedini D.M., Tsoukas C.D. Interaction of 1, 25-dihydroxyvitamin D3 and the immune system. Mol Cell Endocrinol. 43:1985;113-122
33. Thomas M.K., Lloyd Jones D.M., Thadhani R.I., Shaw A.C., Deraska D.J., Kitch B.T., Vamvakas E.C., Dick I.M., Prince R.L., Finkelstein J.S. Hypovitaminosis D in medical inpatients. N Engl J Med. 338:1998;777-783
34. Freaney R., McBrinn Y., McKenna M.J. Secondary hyperparathyroidism in elderly people Combined effect of renal insufficiency and vitamin D deficiency. Am J Clin Nutr. 58:1993;187-191
35. Dawson-Hughes B. Calcium and vitamin D nutritional needs of elderly women. J Nutr. 126:(suppl 4):1996;S1165-S1167
36. Need A.G., Morris H.A., Horowitz M., Nordin C. Effects of skin thickness, age, body fat and sunlight on serum 25-hydroxyvitamin D. Am J Clin Nutr. 58:1993;882-885
37. Jacques P.F., Felson D.T., Tucker K.L., Mahnken B., Wilson P.W., Rosenberg I.H., Rush D. Plasma 25-hydroxyvitamin D and its determinants in an elderly population. Am J Clin Nutr. 66:1997;929-936
38. Mowe M., Bohmer T., Haug E. Serum calcidiol and calcitriol concentrations in elderly people Variations with age, sex, season and disease. Clin Nutr. 15:1996;201-206
39. MacLaughlin J., Holick M.F. Aging decreases capacity of human skin to produce vitamin D3. J Clin Invest. 76:1985;1536-1538
40. O'Dowd K.J., Clemens T.L., Kelsey J.L., Lindsay R. Exogenous calciferol (vitamin D) and vitamin D endocrine status among elderly nursing home residents in the New York City area. J Am Geriatr Soc. 41:1993;414-421
41. Holick M.F. McCollum Award Lecture. Vitamins-new horizons for the 21st century. Am J Clin Nutr. 60:1994;619-630
42. Lips P., van Ginkel F.C., Jongen M.J. Determinants of vitamin D status in patients with hip fracture and in elderly control subjects. Am J Clin Nutr. 46:1987;1005-1010
43. Semba R.D., Garrett E., Johnson B.A., Guralnik J.M., Fried L.P. Vitamin D deficiency among older women with and without disability. Am J Clin Nutr. 72:2000;1529-1534
44. van der Wielen R.P., Lowik M.R., van den Berg H., de Groot L.C., Haller J., Moreiras O., van Staveren W.A. Serum vitamin D concentrations among elderly people in Europe. Lancet. 346:1995;207-210
45. Chapay M.C., Chapay P., Meunier P.J. Calcium and vitamin D supplements Effects on calcium metabolism in elderly people. Am J Clin Nutr. 46:1987;324-328
46. Nierman D.M., Mechanick J.I. Bone hyperresorption is prevalent in chronically critically ill patients. Chest. 14:1998;1122-1128
47. Sebert J.L., Garabedian M., Dechasteigner C., et al. Correction of vitamin D deficiency in the elderly A comparative study of vitamin D2 and vitamin D3. J Bone Miner Res. (Suppl 1):1991;S123
48. McMurtry C.T., Young S.E., Downs R.W., Adler R.A. Mild vitamin D deficiency and secondary hyperparathyroidism in nursing home patients receiving adequate dietary vitamin D. J Am Geriatr Soc. 40:1992;343-347
49. Edidin D.V., Levitsky L.L., Schey W., Dumbovic N., Campos A. Resurgence of nutritional rickets associated with breast-feeding and special dietary practices. Pediatrics. 65:1980;232-235
50. Hayward I., Stein M.T., Gibson M.I. Nutritional rickets in San Diego. Am J Dis Child. 141:1987;1060-1062
51. Kreiter S.R., Schwartz R.P., Kirkman H.N. Jr, Charlton P.A., Calikoglu A.S., Davenport M.L. Nutritional rickets in African American breast-fed infants. J Pediatr. 137:2000;153-157
52. Salle B.L., Glorieux F.H., Lapillone A. Vitamin D status in breastfed term babies. Acta Paediatr. 87:1998;726-727
53. Klein G.L., Horst R.L., Norman A.W. Reduced serum levels of 1, 25-dihydroxyvitamin D during long-term total parenteral nutrition. Ann Intern Med. 94:1981;638-643
54. Shike M., Harrison J.E., Sturtridge W.C., Tam C.S., Bobechko P.E., Jones G., Murray T.M., Jeejeebhoy K.N. Metabolic bone disease in patients receiving long-term total parenteral nutrition. Ann Intern Med. 92:1980;343-350
55. Baer M.T., Kozlowski B.W., Blyler E.M., Trahms C.M., Taylor M.L., Hogan M.P. Vitamin D, calcium and bone status in children with developmental delay in relation to anticonvulsant use and ambulatory status. Am J Clin Nutr. 65:1997;1042-1051
56. Zhou X.J., Vaziri N.D., Segal J.L., Winer R.L., Eltorai I., Brunnemann S.R. Effects of chronic spinal cord injury and pressure ulcer on 25(OH)-vitamin D levels. J Am Parplegia Soc. 16:1992;9-13
57. Arnaud S., Sherrard D.J., Maloney N., Whalen R.T., Fung P. Effects of 1-week head-down tilt bed rest on bone formation and the calcium endocrine system. Aviat Space Environ Med. 63:1992;14-20
58. Bell N.H., Epstein S., Greene A., Shary J., Oexmann M.J., Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest. 76:1985;370-373
59. Trang H.M., Cole D.E., Rubin L.A., Pierratos A., Siu S., Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr. 68:1998;854-858
60. Rosen J.F., Chesney R.W. Circulating calcitriol concentrations in health and disease. J Pediatrics. 103:1983;1-17
61. Compston J.E., Ayers A.B., Horton L.W., Tighe J.R., Creamer B. Osteomalacia after small intestinal resection. Lancet. 1:1978;9-12
62. Lo C.W., Paris P.W., Clemens T.L., Nolan J., Holick M.F. Vitamin D absorption in healthy subjects and in in-patients with intestinal malabsorption syndromes. Am J Clin Nutr. 42:1985;644-649
63. Ireland A.W., Clubb J.S., Neale F.C., Posen S., Reeve T.S. The calciferol requirements of patients with surgical hypoparathyroidism. Ann Intern Med. 69:1968;1-89
64. Rizzoli R., Ammann P., Chevalley T., Bonjour J.P. Protein intake and bone disorders in the elderly. Joint Bone Spine. 68:2001;383-392
65. Aaron J.E., Gallagher J.C., Anderson J., Stasiak L., Longton E.B., Nordin B.E., Nicholson M. Frequency of osteomalacia and osteoporosis in fracture of the proximal femur. Lancet. 1:1974;229-233
66. Lund B., Sorensen O.H., Christensen A.B. 25-Hydroxycholecalciferol and fractures of the proximal femur. Lancet. 2:1975;300-301
67. Long R.G., Skinner R.K., Meinhard E., et al. Serum 25-hydroxyvitamin D in untreated parenchymal and cholestatic liver disease. Lancet. 2:1976;650-652
68. Sokol R.J., Farrell M.K., Heubi J.E., Tsang R.C., Balistreri W.F. Comparison of vitamin E and 25-hydroxyvitamin D absorption during childhood cholestasis. J Pediatr. 103:1983;712-717
69. Heubi J.E., Tsang R.C., Steichen J.J., Chan G.M., Chen I.W., DeLuca H.F. 1, 25-dihydroxyvitamin D3 in childhood hepatic osteodystrophy. J Pediatr. 94:1979;977-982
70. Argao E.A., Heubi J.E., Hollis B.W., Tsang R.C. d-Alpha-tocopherol polyethylene glycol-1000 succinate (TPGS) enhances the absorption of vitamin D in chronic cholestatic liver disease of infancy and childhood. Pediatr Res. 31:1992;146-150
71. Argao E.A., Balistreri W.F., Hollis B.W., Ryckman F.C., Heubi J.E. Effect of orthotopic liver transplantation on bone mineral content and serum vitamin D metabolites in infants and children with chronic cholestasis. Hepatology. 20:1994;598-603
72. Mankin H.J. Rickets, osteomalacia, and renal osteodystrophy, an update. Orthop Clin North Am. 21:1990;81-96
73. Korkor A.B. Reduced binding of [3H]1, 25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure. N Engl J Med. 316:1987;1573-1577
74. Rostand S.G., Drueke T.B. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int. 56:1999;383-392
75. Norman A.W. Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D Integral components of the vitamin D endocrine system. Am J Clin Nutr. 67:1998;1108-1110
76. Bengoa J.M., Bolt M.J., Rosenberg I.H. Hepatic vitamin D25 hydroxylase inhibition by cimetidine and isoniazid. J Lab Clin Med. 104:1984;546-552
77. Tjellesen L., Gotfredsen A., Christiansen C. Different metabolism of vitamin D2/D3 in epileptic patients treated with phenobarbitone/phenytoin. Bone. 7:1986;337-342
78. Tjellesen L., Gotfredsen A., Christiansen C. Different actions of vitamin D2 and D3 on bone metabolism in patient treated with phenobarbitone/phenytoin. Calcif Tissue Int. 37:1985;218-222
79. Tjellesen L., Christiansen C., Rodbro P., Hummer L. Different metabolism of vitamin D2 and vitamin D3 in epileptic patients on carbamazepine. Acta Neurol Scand. 71:1985;385-389
80. Gough H., Goggin T., Bissessar A., Baker M., Crowley M., Callaghan N. A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Q J Med. 230:1986;569-577
81. Buckley L.M., Leib E.S., Cartularo K.S., Vacek P.M., Cooper S.M. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med. 125:1996;961-968
82. Sambrook P., Birmingham J., Kelly P., Kempler S., Nguyen T., Pocock N., Eisman J. Prevention of corticosteroid osteoporosis A comparison of calcium, calcitriol, and calcitonin. N Engl J Med. 328:1993;1747-1752
83. Buckley L.M., Leib E.S., Cartularo K.S., Vacek P.M., Cooper S.M. The effects of low dose corticosteroids on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol. 22:1996;1055-1059
84. Clegg D.O., Egger J., Ward J.R. Osteoporotic vertebral compression fractures in rheumatologic patients treated with prednisone. Arthritis Rheum. 26:(suppl):1983;S47
85. Verstraeten A., Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in post-menopausal patients with rheumatoid arthritis Effect of low dose corticosteroids. Ann Rheum Dis. 45:1986;852-857
86. Rooney M., Davies U.M., Reeve J., Preece M., Ansell B.M., Woo P.M. Bone mineral content and bone mineral metabolism Changes after growth hormone treatment in juvenile chronic arthritis. J Rheumatol. 27:2000;1073-1081
87. Sanchez C.P., Goodman W.G., Brandli D., Goldenhersh M., Murray C., Carlton E., Hahn T., Salusky I.B. Skeletal response to recombinant human growth hormone (rhGH) in children treated with long-term corticosteroids. J Bone Miner Res. 10:1995;2-6
88. Dear K.L.E., Compston J.E., Hunter J.O. Treatments for Crohn's disease that mininize steroid doses are associated with a reduced risk of osteoporosis. Clin Nutr. 20:2001;541-546
89. Sentongo T.A., Semaeo E.J., Stettler N., Piccoli D.A., Stallings V.A., Zemel B.S. Vitamin D status in children, adolescents, and young adults with Crohn's Disease. Am J Clin Nutr. 76:2002;1077-1081
90. Matsuoka L.Y., Wortsman J., Hanifan N., Holick M.F. Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D. Arch Dermatol. 124:1988;1802-1804
91. Matsuoka L.Y., Ide L., Wortsman J., MacLaughlin J.A., Holick M.F. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab. 64:1987;1165-1168
92. Zlotkin S. Vitamin D concentrations in Asian children living in England. BMJ. 318:1999;1417
93. Warden G.D. Fluid resuscitation and early management. Total Burn Care. 2nd ed. 2002;88-97 WB Saunders, London
94. Kagan R., Warden G. Management of the burn wound. Clin Dermatol. 12:1994;47-56
95. Mayes T. Enteral nutrition for the burn patient. Nutr Clin Pract. 12:(suppl 1):1997;S43-S45
96. Mayes T., Gottschlich M.M., Warden G.D. Clinical nutrition protocols for continuous quality improvements in the outcomes of patients with burns. J Burn Care Rehabil. 18:1997;364-368
97. Birke G., Liljedahl S.O., Plantin L.O., Reizenstein P. Studies on burns. Part IX. The distribution and losses through the wound of 131-I-albumin measured by whole-body counting. Acta Chir Scand. 134:1968;27-36
98. Manelli JC, Badetti C, Botti G, Golstein MM, Bernini V, Bernard D. A reference standard for plasma proteins is required for nutritional assessment of adult burn patients. Burns. 199;24:337-345
99. Shenkin A., Neuhauser M., Bergstrom J., Chao L., Vinnars E., Larsson J., Liljedahl S.O., Schildt B., Furst P. Biochemical changes associated with severe trauma. Am J Clin Nutr. 33:1980;2119-2127
100. Marano M.A., Fong Y., Moldawer L.L., Wei H., Calvano S.E., Tracey K.J., Barie P.S., Manogue K., Cerami A., Shires G.T. Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet. 121:1990;32-38. 170:
101. Drost A.C., Burleson D.G., Cioffi W.G. Jr, Jordan B.S., Mason A.D. Jr, Pruitt B.A. Jr. Plasma cytokines following thermal injury and their relationship with patient mortality, burn size, and time postburn. J Trauma. 35:1993;335-339
102. McMillen M.A., Huribal M., Cunningham M.E. Endothelin-1, interleukin-6, and interleukin-8 levels increase in patients with burns. J Burn Care Rehabil. 17:1996;384-389
103. Canalis E. Effect of tumor necrosis factor on bone formation in vitro. Endocrinology. 121:1987;1596-1604
104. Nanes M.S., Rubin J., Titus L., Hendy G.N., Catherwood B. Tumor necrosis factor inhibits 1, 25-dihydroxy-vitamin D3-stimulated bone Gla protein synthesis in rat osteosarcoma cells by a pretranslational mechanism. Endocrinology. 128:1991;2577-2582
105. Gur A., Denli A., Nas K., Cevik R., Karakoc M., Sarac A.J., Erdogan F. Possible pathogenetic role of new cytokines in postmenopausal osteoporosis and changes during calcitonin plus calcium therapy. Rheumatol Int. 22:2002;194-198
106. Horowitz M.C. Cytokines and estrogen in bone Anti-osteoporotic effects. Science. 260:1993;626-627
107. Balto K., Sasaki H., Stashenko P. Interleukin-6 deficiency increases inflammatory bone destruction. Infect Immun. 69:2001;744-750
108. Yakar S., Rosen C.J., Beamer W.G., Ackert-Bicknell C.L., Wu Y., Liu J.L., Ooi G.T., Setser J., Frystyk J., Boisclair Y.R., LeRoith D. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest. 110:2002;771-781
109. Klein G.L., Kikuchi Y., Sherrard D.J., Simmons D.J., Biondo N., Traber D.L. Burn-associated bone disease in sheep Roles of immobilization and endogenous corticosteroids. J Burn Care Rehabil. 17:1996;518-521
110. Klein G.L., Wimalawansa S., Bozak D., Herndon D.N. Acute effects of Pamidronate on bone loss following severe burn. J Burn Care Rehabil. 22:2001;S60
111. Vaughan G.M., Becker R.A., Allen J.P., Goodwin C.W. Jr, Pruitt B.A. Jr, Mason A.D. Jr. Cortisol and corticotrophin in burned patients. J Trauma. 22:1982;263-273
112. Jeffries M.K., Vance M.L. Growth hormone and cortisol secretion in patients with burn injury. J Burn Care Rehabil. 13:1992;391-395
113. Coombes E.J., Batstone G.F. Urine cortisol levels after burns. Burns. 8:1982;333-337
114. Hall G.M., Spector T.D., Griffin A.J., Jawad A.S., Hall M.L., Doyle D.V. The effects of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum. 36:1993;1510-1516
115. Reid I.R., Evans M.C., Wattie D.J. Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patients. Osteoporos Int. 2:1992;103-105
116. Saggese G., Baroncelli G.I., Bertelloni S., Cinquanta L., Di Nero G. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr. 122:1993;37-45
117. Spanos E., Barrett D., MacIntyre I., Pike J.W., Safilian E.F., Haussler M.R. Effect of growth hormone on vitamin D metabolism. Nature. 273:1978;246-247
118. Hart D.W., Herndon D.N., Klein G., Lee S.B., Celis M., Mohan S., Chinkes D.L., Wolf S.E. Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy. Ann Surg. 233:2001;827-834
119. Klein G.L., Wolf S.E., Langman C.B., Rosen C.J., Mohan S., Keenan B.S., Matin S., Steffen C., Nicolai M., Sailer D.E., Herndon D.N. Effect of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury. J Clin Endocrinol Metab. 83:1998;21-24
120. Herndon D.N., Barrow R.E., Kunkel K.R., Broemeling L., Rutan R.L. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg. 212:1990;424-431
121. Herndon D.N., Hawkins H.K., Nguyen T.T., Pierre E., Cox R., Barrow R.E. Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg. 221:1995;649-659
122. Klein G.L., Herndon D.N. Magnesium deficit in major burns Role in hypoparathyroidism and end-organ parathyroid hormone resistance. Magnes Res. 11:1998;103-109
123. Klein G.L., Nicolai M., Langman C.B., Cuneo B.F., Sailer D.E., Herndon D.N. Dysregulation of calcium homeostasis after severe burn injury in children Possible role of magnesium depletion. J Pediatr. 131:1997;246-251
124. Murphey E.D., Chattopadhyay N., Bai M., Kifor O., Harper D., Traber D.L., Hawkins H.K., Brown E.M., Klein G.L. Up-regulation of the parathyroid calcium-sensing receptor after burn injury in sheep A potential contributory factor to postburn hypocalcemia. Crit Care Med. 28:2000;3885-3890
125. Klein G.L., Langman C.B., Herndon D.N. Persistent hypoparathyroidism following magnesium repletion in burn-injured children. Pediatr Nephrol. 14:2000;301-304
126. Szyfelbein S.K., Drop L.J., Martyn J.A. Persistent ionized hypocalcemia in patients during resuscitation and recovery phases of body burns. Crit Care Med. 9:1981;454-458
127. Loven L., Nordstrom H., Lennquist S. Changes in calcium and phosphate and their regulating hormones in patients with severe burn injuries. Scand J Plast Reconstr Surg. 18:1984;49-53
128. Turinsky J., Gonnerman W.A., Loose L.D. Impaired mineral metabolism in postburn muscle. J Trauma. 21:1981;417-422
129. Broughton A., Anderson I., Bowden C.H. Magnesium deficiency syndrome in burns. Lancet. 1:1968;1156-1158
130. Berger M.M., Rothen C., Cavadini C., Chiolero R.L. Exudative mineral losses after serious burns A clue to the alterations of magnesium and phosphate metabolism. Am J Clin Nutr. 65:1997;1473-1487
131. Lennquist S., Lindell B., Nordstrom H., Sjoberg H.E. Hypophosphatemia in severe burns A prospective study. Acta Chir Scand. 145:1979;1-6
132. Loven L., Larsson L., Nordstrom H., Lennquist S. Serum phosphate and 2, 3-diphosphoglycerate in severely burned patients after phosphate supplementation. J Trauma. 26:1986;348-352
133. Dickerson R.N., Gervasio J.M., Sherman J.J., Kudsk K.A., Hickerson W.L., Brown R.O. A comparison of renal phosphorus regulation in thermally injured and multiple trauma patients receiving specialized nutrition support. JPEN J Parenter Enteral Nutr. 25:2001;152-159
134. Holick M.F., MacLaughlin J.-A., Doppelt S.H. Factors that influence the cutaneous photosynthesis of previtamin D3. Science. 211:1981;590-593
135. Gottschlich M.M., Jenkins M., Warden G.D., Baumer T., Havens P., Snook J.T., Alexander J.W. Differential effects of three enteral regimens on selected outcome parameters in burn patients. JPEN J Parenter Enteral Nutr. 14:1990;225-236
136. Gottschlich M.M., Alexander J.W. Fat kinetics and recommended dietary intake in burns. JPEN J Parenter Enteral Nutr. 11:1987;80-85
137. Oxandrin. Physicians' Desk Reference. 2002;1153-1154 Medical Economics Company, Inc, Montvale, NJ
138. Demling R.H., DeSanti L. Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns. J Trauma. 43:1997;47-51
139. Demling R.H. Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury. Burns. 25:1999;215-221
140. Hart D.W., Wolf S.E., Ramzy P.I., Chinkes D.L., Beauford R.B., Ferrando A.A., Wolfe R.R., Herndon D.N. Anabolic effects of oxandrolone after severe burn. Ann Surg. 233:2001;556-564
141. Nutropin. Physicians' Desk Reference. 2002;1417-1425 Medical Economics Company, Inc, Montvale, NJ
142. Ogle G.D., Rosenberg A.R., Calligeros D., Kainer G. Effects of growth hormone treatment for short stature on calcium homeostasis, bone mineralization, and body composition. Horm Res. 41:1994;16-20
143. Binnerts A., Swart G.R., Wilson J.H.P., Hoogerbrugge N., Pols H.A., Birkenhager J.C., Lamberts S.W. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol. 37:1992;79-87
144. Lanes R., Gunczier P., Esaa S., Weisinger J.R. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature A 3-year study. Clin Endocrinol. 57:2002;725-730
145. Gillberg P., Mallmin H., Petren-Mallmin M., Ljunghall S., Nilsson A.G. Two years of treatment with recombinant human growth hormone increases bone mineral density in men with idiopathic osteoporosis. J Clin Endocrinol Metab. 87:2002;4900-4906
146. Burstein S., Chen I.W., Tsang R.C. Effects of growth hormone replacement therapy on 1, 25 dihydroxyvitamin D and calcium metabolism. J Clin Endocrinol Metab. 56:1983;1246-1251
147. Chipman J.J., Zerwekh J., Nicar M., Marks J., Pak C.Y. Effect of growth hormone administration Reciprocal changes in serum 1 alpha, 25-dihydroxyvitamin D and intestinal calcium absorption. J Clin Endocrinol Metab. 51:1980;321-324
148. Wei S., Tanaka H., Kubo T., Ono T., Kanzaki S., Seino Y. Growth hormone increases serum 1, 25-dihydroxyvitamin D levels and decreases 24, 25-dihydroxyvitamin D levels in children with growth hormone deficiency. Eur J Endocrinol. 136:1997;45-51
149. Synthroid. Physicians' Desk Reference. 2002;505-508 Medical Economics Company, Inc, Montvale, NJ
150. Becker R.A., Wilmore D.W., Goodwin C.W. Jr, Zitzka C.A., Wartofsky L., Burman K.D., Mason A.D., Pruitt B.A. Free T4, free T3, and reverse T3 in critically ill, thermally injured patients. J Trauma. 20:1980;713-721
151. Smeds S., Kagedal B., Lieden G., Liljedahl S.O. Thyroid function after thermal trauma. Scand. J Plast Reconstr Surg. 15:1981;141-148
152. Shirani K.Z., Vaughan G.M., Pruitt B.A., Mason A.D. Reduced serum T4 and T3 and their altered serum binding after burn injury in rats. J Trauma. 25:1985;953-958
153. Becker R.A., Vaughan G.M., Goodwin C.W. Jr, Ziegler M.G., Zitzka C.A., Mason A.D. Jr, Pruitt B.A. Jr. Interactions of thyroid hormones and catecholamines in severely burned patients. Rev Infect Dis. 5:(Suppl 5):1983;S908-S913
154. Vaughan G.M., Mason A.D., McManus W.F., Pruitt B.A. Alterations of mental status and thyroid hormones after thermal injury. J Clin Endocrinol Metab. 60:1985;1221-1225
155. Uzzan B., Campos J., Cucherat M., Nony P., Boissel J.P., Perret G.Y. Effects on bone mass of long term treatment with thyroid hormones A meta-analysis. J Clin Endocrinol Metab. 84:1996;4278-4289
156. Langdahl B.L., Loft A.G., Eriksen E.F., Mosekilde L., Charles P. Bone mass, bone turnover and body composition in former hypothyroid patients receiving replacement therapy. Eur J Endocrinol. 134:1996;702-709
157. Mosekilde L., Lund B., Sorensen O.H., Christensen M.S., Melsen F. Serum 25-hydroxycholecalciferol in hyperthyroidism. Lancet. 1:1977;806-807
158. Tjellesen L., Hummer L., Christiansen C., Rodbro P. Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women. Bone Miner. 1:1986;407-413